Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: Lack of association with clinical phenotypes

World Journal of Biological Psychiatry

Volumn 11, Issue 8, 2010, Pages 985-990

  Kocabas, Neslihan Aygun ^a,b   Antonijevic, Irina ^c   Faghel, Carole ^a   Forray, Carlos ^c   Kasper, Siegfried ^d   Lecrubier, Yves ^e   Linotte, Sylvie ^a   Massat, Isabelle ^a   Montgomery, Stuart ^f   Noro, Magali ^a   Oswald, Pierre ^a   Snyder, Lenore ^c   Souery, Daniel ^a   Zohar, Joseph ^g   Mendlewicz, Julien ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b GAZI UNIVERSITY   (Turkey)

^c LUNDBECK RESEARCH USA   (United States)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e INSERM   (France)

^f IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^g SHEBA MEDICAL CENTER   (Israel)

Author keywords

clinical phenotypes; DTNBP1 (dystrobrevin binding protein 1); major depressive disorder (MDD); SNP; treatment response

Indexed keywords

DYSBINDIN;

ADULT; ANXIETY DISORDER; ARTICLE; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MELANCHOLIA; NERVE CELL PLASTICITY; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; SUICIDAL BEHAVIOR; TREATMENT RESPONSE;

ADULT; AGE OF ONSET; AGED; ALLELES; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; CARRIER PROTEINS; COMORBIDITY; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; DRUG RESISTANCE; FEMALE; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SUICIDAL IDEATION;

EID: 78549259726     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2010.512089     Document Type: Article

References (24)

1. Arias B, Serrreti A, Mandelli L, Gasto C, Catalan R, Ronchi DD, Fanasas L. 2009. Dysbindin gene (DTNBP1) in major depression: association with clinical response to selective serotonin reuptake inhibitors. Pharmacogenet Genomics 19:121-128.
2. Benson MA, Newey SE, Martin-Rendon E, Hawkes R, Blake DJ. 2001. Dysbindin, a novel coiled-coil-containing protein interacts with the dystrobrevins in muscle and brain. J Biol Chem 276:24232-24241.
3. Bray NJ, Preece A, Williams NM, Moskvina M, Buckland PR, Owen MJ, O'Donovan MC. 2005. Haplotypes at the dystrobre-vin binding protein 1 gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. Hum Mol Genet 14: 1947-1954.
4. DeRosse P, Funke B, Burdick KE, Lencz T, Ekholm JM, Kane JM, et al. 2006. Dysbindin genotype and negative symptoms in schizophrenia. Am J Psychiatry 63:532-534.
5. Fallgatter AJ, Herrmann MJ, Hohoff C, Ehlis AC, Jarczok TA, Freitag CM, Deckert J. 2006. DTNBP1 (dysbindin) gene variants modulate prefrontal brain function in healthy individuals. Neuropsychopharmacology 31:2002-2010.
6. Gaysina D, Cohen-Woods S, Chow PC, Martucci L, Schosser A, Ball HA, et al. 2009. Association of the dystrobrevin binding protein 1 gene (DTNBP1) in a bipolar case-control study. Am J Med Genet B Neuropsychiatr Genet 150:836-844.
7. Guo AY, Sun J, Riley BP, Thiselton DL, Kendler KS, Zhao Z. 2009. The dystrobrevin binding protein 1 gene: features and networks. Mol Psychiatry 14:18-29.
8. Harrison PJ, Weinberger DR. 2005. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10:40-68.
9. Hattori S, Murotani T, Matsuzaki S, Ishizuka T, Kumamoto N, Takeda M, et al. 2008. Behavioral abnormalities and dopamine reductions in sdy mutant mice with a deletion in DTNBP1: a susceptibility gene for schizophrenia. Biochem Biophys Res Commun 373:298-302.
10. Kim JJ, Mandelli L, Pae CU, Ronchi DD, Jun TY, Lee C, et al. 2008. Is there a protective haplotype of dysbindin gene (DTNBP1) 3 polymorphisms for major depressive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 32:375-379.
11. Levinson DF. 2006. The genetics of depression: a review. Biol Psychiatry 60:84-92.
12. Li W, Zhang Q, Oiso N, Novak EK, Gautam R, O'Brien EP, et al. 2003. Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Nature Genet 35: 84-89.
13. Li D, He L. 2007. Association study between the dystrobrevin binding protein 1 gene ( DTNBP1 ) and schizophrenia: A meta analysis. Schizophr Res 96:112-118.
14. Pae CU, Serretti A, Mandelli L, Ronchi DD, Patkar AA, Jun TY, et al. 2007. Dysbindin associated with selective serotonin reup-take inhibitor antidepressant efficacy. Pharmacogenet Genomics 17:69-75.
15. Pae CU, Ronchi DD, Mandelli L, Patkar AA, Jun TY, Serretti A. 2009. Dysbindin gene (DTNBP1) and schizophrenia in Korean population. Eur Arch Psychiatry Clin Neurosci 259: 137-142.
16. Riley B, Kuo PH, Maher BS, Fanous AH, Sun J, Wormley B, et al. 2009. The dystrobrevin binding protein 1 gene (DTNBP1) is associated with schizophrenia in the Irish case Control Study of Schizophrenia (ICCSS) sample. Schizophr Res 115: 245-253.
17. Souery D, Oswald P, Massat I, Bailer U, Bollen J, Demyttenaere K, et al. 2007. Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. J Clin Psychiatry 68:1062-1070.
18. Straub RE, Jiang Y, MacLean CJ, Ma Y, Webb BT, Myakishev MV, et al. 2002. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 71:337-348.
19. Weickert CS, Straub RE, McClintock BW, Matsumoto M, Hashimoto R, Hyde TM, et al. 2004 . Human Dysbindin gene (DTNBP1) expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch Gen Psychiatry 6:544-555.
20. Wessman J, Paunio T, Tuulio-Henriksson A, Koivisto M, Partonen T, Suvisaari J, et al. 2009. Mixture model clustering of pheno-type features reveals evidence for association of DTNBP1 to a specific subtype of schizophrenia. Biol Psychiatry 66: 990-996.
21. Wirgenes KV, Djurovic S, Agartz I, Jonsson EG, Werge T, Melle I, Andreassen OA, 2009. Dysbindin and D-amino-acid-oxidase gene polymorphisms associated with positive and negative symptoms in schizophrenia. Neuropsychobiology 60:31-36.
22. Wray NR, James MR, Handoko HY, Dumenil T, Lind PA, Montgomery GW, Martin NG. 2008. Association study of candidate variants from a brain-derived neurotrophic factor and dystro-brevin-binding protein 1 with neuroticism, anxiety and depression. Psychiatr Genet 18:219-225.
23. Yagasaki Y, Numakawa T, Kumamaru E, Hayashi T, Su TP, Kunugi H. 2006. Chronic antidepressants potentiate via sigma-1 receptors the brain-derived neurotrophic factor induced signaling for glutamate release. J Biol Chem 281: 12941-12949.
24. Zill P, Baghai TC, Engel R, Zwanzger P, Schule C, Eser D, et al. 2004.The dysbindin gene in major depression: An association study. Am J Med Genet B Neuropsychiatr Genet 129:55-58.